Business ❯ Healthcare ❯ Biotechnology

Clinical Trials

Drug Development FDA Approval Process Gedatolisib Development Oncology Regulatory Affairs Cell Therapy Drug Delivery Osteoarthritis Immune-Modulating Therapies Cancer Treatments Pharmaceutical Partnerships Oral Therapeutics Psychedelic Treatments Precision Medicine T Cell Therapy CAR-T Therapy MannKind Corporation Cancer Treatment Monoclonal Antibodies Immunogenicity

AstraZeneca Buys Stake in Summit to Pursue Cancer Drug Combinations

The equity purchase funds a research pact to test ivonescimab with AstraZeneca’s cancer medicines to speed combination trials.

Stories older than 24h

Capricor Hit with Multiple Investor Lawsuits After FDA Questions Unagreed Trial Analysis

Vaxcyte COO Sells 6,182 Shares After Exercising Deep-Discount Options

Capricor Faces Securities Class Action After FDA Questions Deramiocel Analysis

Cedar Grove’s Q1 Letter Reaffirms Stock-Picking Focus, Highlights Evolv, The RealReal and Abivax

ImmunityBio Extends Rally to 52-Week High on Anktiva Sales, Saudi Approval and Trial Progress

aTyr Investors Face Dec. 8 Deadline as Rival Lawsuits Over Failed Sarcoidosis Trial Intensify

Enlivex Raises $212 Million to Build RAIN Token Treasury, Plans Matteo Renzi Board Appointment

Rani Therapeutics and Chugai Sign Oral Biologics Collaboration Worth Up to $1.085 Billion

BioRestorative Prices $1.085 Million Direct Offering at $1.60 With Concurrent Warrants

FDA Approves Papzimeos as First Therapy for Adult Recurrent Respiratory Papillomatosis